Related Content
Sept. 8, 2026 — Abbot has announced that it has received U.S. Food and Drug Administration (FDA) approval for the ...
September 08, 2026
Aug. 31, 2026 — At the European Society of Cardiology Congress in Munich, Abbott announced new late-breaking 12-month ...
September 02, 2026
Aug. 4, 2026 — Abbott has completed enrollment in its TECTONIC coronary artery disease (CAD) Intravascular Lithotripsy ...
August 06, 2026
July 7, 2026 —AtaCor Medical has announced the enrollment of the first patient in the company's ALARION-EV trial ...
July 09, 2026
April 14, 2026 — Implicity, a provider of remote patient monitoring and cardiac data management solutions, recently ...
April 14, 2026
Feb. 27, 2026 — The U.S. Food and Drug Administration (FDA) has approved Abbott’s CardioMEMS Hero device — a pulmonary ...
February 27, 2026
March 27, 2025 — Abbott recently announced it has received CE Mark in Europe for the Volt PFA System to treat patients ...
March 27, 2025
March 25, 2024 — Abbott announced the first patient has been enrolled in the ENVISION investigational device exemption ...
March 25, 2024
February 15, 2024 — Abbott announced that the Circulatory System Devices Panel of the Medical Devices Advisory Committee ...
February 15, 2024
July 26, 2023 — Abbott is recalling the Amplatzer Steerable Delivery Sheath due to an increased risk for air emboli to ...
July 26, 2023